Acridone compounds
US9399625B2 · kind B2 · utility
0Cited by
19References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 16, 2015 |
| Grant date | Jul 26, 2016 |
| Priority date | — |
| Expiry date | Feb 16, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
(A1) A class of acridone compounds has been discovered that exhibits chemosensitizing and antiparasitic activity. Described herein are pharmaceutical compositions and methods for their use to treat parasitic infections, such as malaria and toxoplasmosis, and to sensitize resistant cells, such as multidrug resistant cells to other therapeutic agents. The pharmaceutical compositions and methods may also be used to treat and/or prevent psychotic diseases such as schizophrenia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.